Pharmacological Evaluation of Signals of Disproportionality Reporting Related to Adverse Reactions to Antiepileptic Cannabidiol in VigiBase

Cannabidiol is the first cannabis-derived drug approved for the treatment of Lennox–Gastaut syndrome, Dravet syndrome, and Tuberous Sclerosis Complex. In the current study, we performed a descriptive analysis followed by a disproportionality analysis of potential adverse events caused by CBD extract...

Descripción completa

Detalles Bibliográficos
Autores principales: Calapai, Fabrizio, Mannucci, Carmen, McQuain, Liana, Salvo, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610535/
https://www.ncbi.nlm.nih.gov/pubmed/37895891
http://dx.doi.org/10.3390/ph16101420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610535/
https://www.ncbi.nlm.nih.gov/pubmed/37895891
http://dx.doi.org/10.3390/ph16101420

Ejemplares similares